IHI:ARCA-iShares U.S. Medical Devices

ETF | Health | NYSE Arca

Last Closing Price

USD 216.02

Change

+7.05 (+3.37)%

Market Cap

USD 2.96B

Volume

0.17M

Average Target Price

N/A
Average Analyst Rating

N/A

STA Verdict

Verdict

About

The investment seeks to track the investment results of the Dow Jones U.S. Select Medical Equipment Index composed of U.S. equities in the medical devices sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index includes medical equipment companies such as manufacturers and distributors of medical devices such as magnetic resonance imaging (MRI) scanners, prosthetics, pacemakers, X-ray machines, and other non-disposable medical devices. The fund is non-diversified.

Inception Date: 01/05/2006

Primary Benchmark: DJ US Select Medical Equip TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.44%

Management Expense Ratio: 0.43 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2018-10-16 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
XLV SPDR Select Sector Fund - Heal.. 0.14 %

+2.48 (+2.74%)

USD 19.04B
VHT Vanguard Health Care 0.10 %

+5.29 (+3.11%)

USD 8.73B
XBI SPDR Series Trust S&P Biotech 0.35 %

+4.51 (+5.31%)

USD 5.21B
FBT First Trust Amex Biotech Index.. 0.56 %

+6.25 (+4.37%)

USD 3.31B
IYH iShares U.S. Healthcare 0.43 %

+5.64 (+2.94%)

USD 2.38B
IXJ iShares Global Healthcare 0.47 %

+1.52 (+2.53%)

USD 1.74B
FHLC Fidelity MSCI Health Care Inde.. 0.08 %

+1.35 (+3.06%)

USD 1.47B
FXH First Trust Health Care AlphaD.. 0.62 %

+2.62 (+3.35%)

USD 1.30B
IHF iShares U.S. Health Care Provi.. 0.43 %

+5.80 (+3.05%)

USD 1.04B
HQH Tekla Healthcare Investors 0.00 %

+0.77 (+3.65%)

USD 0.92B

ETFs Containing IHI

ETAC:CA Equium Global Tactical Al.. 9.44 % 1.76 %

N/A

CAD 9.06M
LDRS Innovator IBD ETF Leaders 5.81 % 0.00 %

+0.73 (+3.15%)

USD 0.04B

Market Performance

  Market Performance vs.
Industry/Classification (Health)
Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 24.50% 93% A 93% A
Dividend Return 0.14% 14% F 1% F
Total Return 24.64% 93% A 92% A-
Trailing 12 Months  
Capital Gain 28.13% 89% B+ 92% A-
Dividend Return 0.30% 23% F 4% F
Total Return 28.43% 89% B+ 91% A-
Trailing 5 Years  
Capital Gain 145.64% 100% A+ 95% A
Dividend Return 4.61% 42% F 13% F
Total Return 150.25% 100% A+ 94% A
Average Annual (5 Year Horizon)  
Capital Gain 19.07% 96% A 90% A-
Dividend Return 19.82% 93% A 89% B+
Total Return 0.75% 48% F 15% F
Risk Return Profile  
Volatility (Standard Deviation) 8.41% 89% B+ 75% C
Risk Adjusted Return 235.69% 100% A+ 99% A+
Market Capitalization 0.98B 86% B 70% C-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

IHI:ARCA-iShares U.S. Medical Devices

ETF | Health | NYSE Arca

Last Closing Price

USD 216.02

Change

+7.05 (+3.37)%

Market Cap

USD 2.96B

Volume

0.17M

Average Target Price

N/A
Average Analyst Rating

N/A

STA Verdict

Verdict

Values as of: 2018-10-16